Please assess the completion status of the following clinical trial:

Trial Title: Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* One to 2 painful vertebrae (T1-L5) with evidence of osteolytic metastatic lesion with known primary histology with pathologic fracture(s) at index vertebra by MRI~* Pain score ≥ 4 on the numerical rating pain scale~* Life expectancy of ≥ 6 months~Exclusion Criteria:~* Primary tumors of the bone at index vertebra~* Benign tumors of the bone at index vertebra~* Osteoblastic tumors at index vertebra~* Index vertebra with more than one (1) pedicle involved~* Epidural extension of tumor within 5 mm of the spinal cord or without sufficient room for thermal protective maneuvers~* Spinal cord compression or canal compromise requiring decompression~* Radiation therapy is planned to be started on the index vertebra within 4 weeks post procedure~* Radiation therapy was performed on the index vertebra within 2 months before enrollment~* Major surgery of the spine was performed within 3 months before enrollment~* Index vertebra(e) had previous spine surgery including vertebroplasty or kyphoplasty~* Additional non-kyphoplasty/vertebroplasty surgical treatment is required for the index vertebra

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- RF Ablation and Vertebral Augmentation (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).